5-HT4 Receptor

The 5-HT4 receptor is a G-protein-coupled receptor that mediates physiological effects in the central nervous system and periphery[1]. Mechanistically, 5-HT4 receptor activation stimulates adenylyl cyclase, increases cAMP/CREB signaling, and regulates memory-related hippocampal processes[2]. In Alzheimer’s disease models, 5-HT4 receptor agonists increased sAPPα in cortex and hippocampus and supported the non-amyloidogenic pathway of APP metabolism[3][4]. In gastrointestinal models, 5-HT4 receptor agonists activated myenteric plexus neurons, released acetylcholine, and inhibited leukocyte infiltration in postoperative ileus[5]. In injured lower gut anastomosis, mosapride increased new enteric neurons, while SB-207266 abolished this effect[6]. Compared with related isoforms, human 5-HT4 splice variants differ functionally because C-terminal tails and splicing can influence ligand pharmacology[7][8]. For experimental applications, prucalopride, mosapride, tegaserod, GR113808, SB204070, and SB-207266 provide agonist or antagonist tools for studying 5-HT4 receptor signaling, neurogenesis, motility, and isoform-specific pharmacology[3][6][7][9].
References: